Inadequate antioxidant defenses attributable to low levels of antioxidants (for example, vitamin C and vitamin E) or variations in the expression or function of enzymatic antioxidants (glutathione-S-transferases [GSTs]), offer promising chemoprevention targets to reduce the burden of asthma [49]. Here, HPGDS is linked to asthma.